[img_assist|nid=194|title=|desc=|link=none|align=right|width=100|height=43]Increasingly stem cells from umbilical cord blood (UCB) enter the biomedical and biopolitical discussions about stem cells: as «donation» and baby's «First gift», as biological «life insurance» or as life saving «therapeutic» for a sibling.
Is umbilical cord blood banking a live insurance for a newborn baby, or a commercial enterprise that promises much too much? What problems are bound to follow it?